Investor mix
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Accelerator & incubator | 1 | 25% |
| Other / undisclosed | 2 | 50% |
Developer of T-cell receptor-based therapeutics for cancer and autoimmune diseases
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Accelerator & incubator | 1 | 25% |
| Other / undisclosed | 2 | 50% |